BlueSphere Bio Nachrichten und Aktivitäten
Führungskräfte
Siehe das Organigramm mit seine 11 wichtigsten Führungskräfte
Die meist gesuchten Biographien bei BlueSphere Bio
- Keir Loiacono, Chief Executive Officer and Director
- Jeanne Cunicelli, Board Member
- Rob Lin, Director
Letzte Veränderungen der Führungskräfte auf BlueSphere Bio
- Alan Korman der/die zuvor Board Member war, wird Chief Scientific Officer (Nachrichten veröffentlicht am 19, Mai 2025).
Eine Benachrichtigung erstellen
um Veränderungen bei Führungskräften von BlueSphere Bio nachzuverfolgen.
Biotechnologie
BlueSphere Bio hat 2.350 Konkurrenten , einschließlich Astellas Gene Therapies (USA), Eurofins (Luxemburg) und Lonza (Schweiz).
Popular M&A news in Biotechnologie
- Sirius Therapeutics hat gerade eine Spendenaktion von 50 Millionen Dollar angekündigt. (veröffentlicht am 16, Juni 2025).
- BioNTech has announced the acquisition of CureVac (veröffentlicht am 12, Juni 2025).
- SpliceBio hat gerade eine Spendenaktion von 135 Millionen Dollar angekündigt. (veröffentlicht am 11, Juni 2025).
Andere vorgeschlagene Kontakte der Biotechnologie branche
Nachrichten
Neueste Pressemitteilungen nach BlueSphere Bio
- BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer | BlueSphere Bio
- BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial | BlueSphere Bio
- BlueSphere Bio Accepted as Member of Johnson & Johnson Innovation-JLABS | BlueSphere Bio
- BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial
- BlueSphere Bio Announces IND Clearance of its First in Human Candidate and New Cell Therapy Portfolio for High-Risk Leukemia Patients | BlueSphere Bio
- BlueSphere Bio Establishes Strategic Collaboration with the National Cancer Institute to Advance Treatments for Rare Respiratory Disease | BlueSphere Bio
- BlueSphere Bio to Present Corporate Update and Participate in a Panel Discussion at the 2024 BIO International Convention | BlueSphere Bio
- BlueSphere Bio to Present at the Next Generation CAR & T Cell Therapies Conference | BlueSphere Bio
- BlueSphere Bio to Present at the 25th Annual BIO CEO & Investor Conference | BlueSphere Bio
- BlueSphere Bio Appoints Erkut Bahceci, M.D., as Chief Medical Officer | BlueSphere Bio
- View more press releases Close
Social media about BlueSphere Bio
- BlueSphere Bio auf Wikipedia, Google News & Yahoo Finance
- BlueSphere Bio auf LinkedIn, Twitter & YouTube
